Mobile Menu - Open Mobile Menu - Closed

Text Size: A A A

Congresswoman Brenda Lawrence

Representing the 14th District of Michigan

U.S. Rep. Lawrence Announces $268 Million Grant Award to Support Health Providers in Southeast Michigan

May 8, 2020
Press Release

Washington, D.C. – Today, Representative Brenda L. Lawrence (MI-14) announced a total of $268,858,491 in grants awarded to Michigan’s 14th Congressional District from the Department of Health and Human Services (HHS) as a part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act provided $172 billion for health professionals to purchase medical supplies and care for patients diagnosed with COVID-19. The funding was awarded through multiple HHS grant programs, including the FY 2020 Expanding Capacity for Coronavirus Testing (ECT) and the FY 2020 Coronavirus Supplemental Funding for Health Centers.

“Health centers across the state are working around the clock to care for the thousands of Michiganders diagnosed with COVID-19. The grant money will provide critical support to frontline healthcare workers and ensure they can carry out their jobs in the safest manner possible,” said Rep. Lawrence. “We cannot afford to let hospitals and health centers fold when more than a million Americans have tested positive for this virus. For weeks, I have been discussing the importance of expanded testing capabilities, and I am thrilled to see nearly $2 million in grants to expand testing capacity. The fastest way to emerge from this pandemic is through a rigorous and widespread testing strategy, including expanding access to mobile testing in hotspots that need it the most. These grants will help Southeast Michigan get closer to that goal.”

 

###

 

Background:

  • The CARES Act provided $172 billion for health professionals nationwide;
  • $268,858,491 in grant funding has been awarded to health care facilities around the 14th Congressional District, including large portions of Wayne, Oakland County;
  • These grants assist relief projects and COVID-19 response measures;
  • $1,967,593 is specifically designated for expanding testing capacity.